TORNTPHARMBSETORRENT PHARMACEUTICALS L· PharmaceuticalsMediumNeutral
Announced Wed, 7 Oct, 2026 · 19:31 IST

Credit rating outlook revised from stable to positive at IND AA+

Rating UpgradedCredit & Debt View source PDFExplain this filing

TORNTPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
—1-day move
₹4690.00
prior close
₹4713.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2+0.0+0.0-0.5——————————
Up moveDown movePending
AI summary

India Ratings has affirmed Torrent Pharma's credit rating at IND AA+ and revised the outlook from stable to positive for existing banking facilities, issuer rating, and Non-Convertible Debentures. The commercial paper rating was affirmed and assigned at IND A1+. The positive outlook signals expected improvement in the company's credit profile and financial metrics over the medium term.

Likely market impact

Positive outlook upgrade reflects a stronger credit profile; may support lower borrowing costs and points to a possible future rating upgrade.